Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression
- PMID: 33180882
- PMCID: PMC7660522
- DOI: 10.1371/journal.ppat.1008949
Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression
Abstract
The COVID-19 has emerged as an epidemic, causing severe pneumonia with a high infection rate globally. To better understand the pathogenesis caused by SARS-CoV-2, we developed a rhesus macaque model to mimic natural infection via the nasal route, resulting in the SARS-CoV-2 virus shedding in the nose and stool up to 27 days. Importantly, we observed the pathological progression of marked interstitial pneumonia in the infected animals on 5-7 dpi, with virus dissemination widely occurring in the lower respiratory tract and lymph nodes, and viral RNA was consistently detected from 5 to 21 dpi. During the infection period, the kinetics response of T cells was revealed to contribute to COVID-19 progression. Our findings implied that the antiviral response of T cells was suppressed after 3 days post infection, which might be related to increases in the Treg cell population in PBMCs. Moreover, two waves of the enhanced production of cytokines (TGF-α, IL-4, IL-6, GM-CSF, IL-10, IL-15, IL-1β), chemokines (MCP-1/CCL2, IL-8/CXCL8, and MIP-1β/CCL4) were detected in lung tissue. Our data collected from this model suggested that T cell response and cytokine/chemokine changes in lung should be considered as evaluation parameters for COVID-19 treatment and vaccine development, besides of observation of virus shedding and pathological analysis.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
![Fig 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g001.gif)
![Fig 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g002.gif)
![Fig 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g003.gif)
![Fig 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g004.gif)
![Fig 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g005.gif)
![Fig 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g006.gif)
![Fig 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g007.gif)
![Fig 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7660522/bin/ppat.1008949.g008.gif)
Similar articles
-
Role of inflammatory markers in corona virus disease (COVID-19) patients: A review.Exp Biol Med (Maywood). 2020 Sep;245(15):1368-1375. doi: 10.1177/1535370220939477. Epub 2020 Jul 7. Exp Biol Med (Maywood). 2020. PMID: 32635752 Free PMC article. Review.
-
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.Nature. 2020 Sep;585(7824):273-276. doi: 10.1038/s41586-020-2423-5. Epub 2020 Jun 9. Nature. 2020. PMID: 32516797 Free PMC article.
-
Early Insights into Immune Responses during COVID-19.J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8. J Immunol. 2020. PMID: 32513850 Review.
-
Respiratory disease in rhesus macaques inoculated with SARS-CoV-2.Nature. 2020 Sep;585(7824):268-272. doi: 10.1038/s41586-020-2324-7. Epub 2020 May 12. Nature. 2020. PMID: 32396922 Free PMC article.
-
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.Science. 2020 May 29;368(6494):1012-1015. doi: 10.1126/science.abb7314. Epub 2020 Apr 17. Science. 2020. PMID: 32303590 Free PMC article.
Cited by
-
SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023.Emerg Infect Dis. 2024 Jun;30(6):1253-1257. doi: 10.3201/eid3006.231247. Emerg Infect Dis. 2024. PMID: 38782139 Free PMC article.
-
The critical impacts of cytokine storms in respiratory disorders.Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15. Heliyon. 2024. PMID: 38694122 Free PMC article. Review.
-
Molecular and Serological Studies on Potential SARS-CoV-2 Infection among 43 Lemurs under Human Care-Evidence for Past Infection in at Least One Individual.Animals (Basel). 2023 Dec 31;14(1):140. doi: 10.3390/ani14010140. Animals (Basel). 2023. PMID: 38200871 Free PMC article.
-
The panzootic potential of SARS-CoV-2.Bioscience. 2023 Dec 18;73(11):814-829. doi: 10.1093/biosci/biad102. eCollection 2023 Nov. Bioscience. 2023. PMID: 38125826 Free PMC article.
-
Animal models to study the neurological manifestations of the post-COVID-19 condition.Lab Anim (NY). 2023 Sep;52(9):202-210. doi: 10.1038/s41684-023-01231-z. Epub 2023 Aug 24. Lab Anim (NY). 2023. PMID: 37620562 Free PMC article. Review.
References
-
- Patel A, Jernigan DB, Abdirizak F, Abedi G, Aggarwal S, Albina D, et al. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. American Journal of Transplantation. 2020;20(3):889–95. 10.1111/ajt.15805 - DOI - PMC - PubMed
-
- WHO. Coronavirus disease (COVID-19) Pandemic. Available at https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019. 2020.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous